Submitting OIG:
Report Description:
Medicare Part D is an optional program to help Medicare beneficiaries pay for prescription drugs. For drugs dispensed to Part D beneficiaries, Part D prescription drug plan sponsors may receive direct and indirect remuneration (DIR), which consists of rebates, subsidies, or other price concessions that decrease the costs that a sponsor incurs for a Part D drug. Part D sponsors or their pharmacy benefit managers (PBMs) may negotiate with pharmacies to charge various fees, and these fees are included as DIR. Part D sponsors are required to report their DIR to the Centers for Medicare & Medicaid Services (CMS) each year.
Date Issued:
Thursday, October 31, 2019
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
A-03-18-00006
Component, if applicable:
Centers for Medicare & Medicaid Services
Location(s):
Agency-Wide
Type of Report:
Audit
Questioned Costs:
$469,850
Funds for Better Use:
$0
Number of Recommendations:
1
View Document:
Attachment | Size |
---|---|
31800006 Audit of Medicare Part D.pdf | 532.26 KB |
Additional Details Link: